Mapping the Path for Commercial Delivery
Digital health is now seeing a rapidly growing array of innovative technologies and applications which are starting to grab consumer attention, especially as the larger, more established corporations move into this space. These advancements are showing that the industry will inevitably give rise to greater investment and business opportunities.
However, the map showing the path to healthcare’s effective digital transformation is not entirely clear and small tech companies and venture capitalists still dominate the market. Commercial business models, reimbursement methods and market-wide consumer acceptance still need to be identified and proven and as with other industries before digital health, regulation will undoubtedly play a key role in allowing this to happen.
The FT Digital Health Summit USA will build upon the Financial Times' expertise and knowledge of healthcare, life sciences and digital business to set out a stakeholder roadmap for upscaling America’s digital health industry, which in terms of investment, innovation and market share is far ahead of any other region. Key figures from throughout the healthcare, technology and investment arena will come together to set the agenda for overcoming the barriers towards a sustainable digital transition of US healthcare.